Hengan International Group Company Limited (1044.HK)
| Previous close | 39.550 |
| Open | 39.800 |
| Bid | 40.100 x 0 |
| Ask | 40.150 x 0 |
| Day's range | 39.550 - 40.750 |
| 52-week range | 36.800 - 58.500 |
| Volume | |
| Avg. volume | 2,435,820 |
| Market cap | 46.601B |
| Beta (5Y monthly) | 0.41 |
| PE ratio (TTM) | 10.92 |
| EPS (TTM) | 3.671 |
| Earnings date | 17 Mar 2022 - 21 Mar 2022 |
| Forward dividend & yield | 2.76 (6.97%) |
| Ex-dividend date | 10 Sep 2021 |
| 1y target est | 47.60 |
- Business Wire
Perimeter Medical Imaging AI Announces U.S. FDA 510(k) Clearance for OCT Imaging System
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Perimeter’s Optical Coherence Tomography (OCT) Imaging System (v2.1), which is designed to examine tissue microstructures during surgical procedures by providing cross-sectional, real-time margin visualization.
- Business Wire
Perimeter Medical Imaging AI Provides Update on Exercise of Warrants
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, today provided an update on its previously announced acceleration of the expiry date of the share purchase warrants issued by the Company on June 29, 2020 (the "Warrants").
